SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-013512
Filing Date
2020-02-10
Accepted
2020-02-10 16:16:46
Documents
2
Period of Report
2020-02-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207251d1_8k.htm 8-K 21784
2 EXHIBIT 99.1 tm207251d1_ex99-1.htm EX-99.1 20796
  Complete submission text file 0001104659-20-013512.txt   43920
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 20592148
SIC: 2836 Biological Products, (No Diagnostic Substances)